Sanctuary Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.84M Buy
107,276
+10,329
+11% +$904K 0.05% 406
2026
Q1
$8.26M Buy
96,947
+17,577
+22% +$1.57M 0.04% 417
2025
Q4
$6.27M Sell
79,370
-3,260
-4% -$256K 0.03% 489
2025
Q3
$6.61M Sell
82,630
-14,262
-15% -$1.22M 0.04% 448
2025
Q2
$8.81M Buy
96,892
+2,558
+3% +$234K 0.05% 349
2025
Q1
$8.84M Sell
94,334
-10,299
-10% -$922K 0.06% 322
2024
Q4
$9.51M Sell
104,633
-6,638
-6% -$633K 0.06% 324
2024
Q3
$10.6M Buy
111,271
+13,434
+14% +$1.37M 0.07% 300
2024
Q2
$8.9M Buy
+97,837
New +$9.03M 0.06% 310

Other funds holding CL

Sanctuary Advisors's CL Position: Q2 2026 in Review

Sanctuary Advisors increased its Colgate-Palmolive (CL) stake by 11% in Q2 2026, buying an estimated $904K and bringing the position to 107,276 shares worth $9.84M. The position accounts for 0.05% of the portfolio, ranked #406.

Sanctuary Advisors first reported a position in CL in Q2 2024 and has held it in 9 quarters since. The position peaked at $10.6M in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Sanctuary Advisors held 107,276 shares of Colgate-Palmolive worth $9.84M as of Q2 2026.
  • Sanctuary Advisors bought 10,329 Colgate-Palmolive shares in Q2 2026, an estimated $904K.
  • Colgate-Palmolive made up 0.05% of Sanctuary Advisors's portfolio in Q2 2026, its #406 holding.
  • Sanctuary Advisors first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Colgate-Palmolive position peaked at $10.6M in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.